Since RU–486 is not easily available in India, Misoprostol Alone Abortion trial will be conducted at the Pune Center.

All women had a positive response to E.C.P.

Only 12 patients (4.6%) had used E.C.P when the 1st follow–up of 261 patients was done and 1 patient (0.65) had used E.C.P during the second follow up of 166 patients.

None of the patients had used E.C.P when the 3rd or 4th follow–up was done.

12/13 (92%) patients who had used E.C.P belonged to the info pill group and1/13 (8%) patients belonged to the info group. This suggests that if pills are given in advance there is a tendency for women to use E.C.P. when needed.

12/13 (92%) of the patients used E.C.P as per schedule.

In all the patients who used E.C.P only 5/13 (38%) patients had headache, 3/13 (23%) patients had nausea and 2/13 patients (15%) had vomiting.

Most of the E.C.P users 12/13 (92%) had no change in the next menstrual cycle, only 1/13 patients (8%) had delayed menstrual periods.

All those patients who had used E.C.P were not pregnant when followed up again.

11/13 (85%) of patients who had used E.C.P were satisfied with the E.C.P use and 7/13 (54%) would use this regimen if needed again.

Male Involvement In Surgical And Medical Abortion In India:
Knowledge, Attitudes And Impact On Decision Making.